Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds RBC Capital Maintains Sector Perform on Maxar Technologies, Maintains $53 Price Target

RBC Capital Maintains Sector Perform on Maxar Technologies, Maintains $53 Price Target

RBC Capital analyst Ken Herbert maintains Maxar Technologies (NYSE:MAXR) with a Sector Perform and maintains $53 price target.

byBenzinga Newsdesk

February 23, 2023

1 minute read

RBC Capital analyst Ken Herbert maintains Maxar Technologies (NYSE:MAXR) with a Sector Perform and maintains $53 price target.

Analyst Ratings

Analyst Ratings for Lowe’s Companies

By Benzinga Insights

July 20, 11:09 AM

Analysts have provided the following ratings for Lowe's Companies (NYSE:LOW) within the last quarter:

LOW

Amazon, Meta, and Google: Analysts Reveal Unseen Insights for 2024

By Anusuya Lahiri

December 27, 1:53 PM

Wedbush analysts led by Scott Devitt painted their internet outlook for 2024. Looking ahead to 2024, the analysts noted that leading consumer internet platforms remain well positioned with rising margins and improving industry growth rates across eCommerce and digital advertising.

AMZN

What’s Going On With T2 Biosystems Stock?

By Erica Kollmann

October 19, 12:21 PM

T2 Biosystems, Inc. (NASDAQ: TTOO) shares are trading lower Thursday.

TTOO

FDA Slams Break On Fulcrum Therapeutics’ Sickle Cell Disease Study, Shares Plummet

By Vandana Singh

February 24, 12:41 PM

The FDA verbally informed Fulcrum Therapeutics Inc (NASDAQ:FULC) that it has issued a full clinical hold regarding the Investigational New Drug (IND)…

FULC

RBC Capital Maintains Sector Perform on Maxar Technologies, Maintains $53 Price Target

Related Posts

Analyst Ratings for Lowe’s Companies

Amazon, Meta, and Google: Analysts Reveal Unseen Insights for 2024

What’s Going On With T2 Biosystems Stock?

FDA Slams Break On Fulcrum Therapeutics’ Sickle Cell Disease Study, Shares Plummet